MYRIAD GENETICS, INC. Weighted Average Number of Shares Outstanding, Basic and Diluted
MYRIAD GENETICS, INC. (MYGN) reported Weighted Average Number of Shares Outstanding, Basic and Diluted of 74.70 million shares for the 3-month period ending 2020-09-30, per its 10-Q filed 2020-11-09.
Discontinued › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted · last filed 2020-11-09
- MYRIAD GENETICS, INC. weighted average number of shares outstanding, basic and diluted for the quarter ending 2020-09-30 was 74.70M shares, a 1.36% increase year-over-year.
- MYRIAD GENETICS, INC. weighted average number of shares outstanding, basic and diluted for the quarter ending 2019-09-30 was 73.70M shares.
| Period end | Weighted Average Number of Shares Outstanding, Basic and Diluted 3 month |
|---|---|
| 2020-09-30 | 74.70M shares 10-Q · filed 2020-11-09 |
| 2019-09-30 | 73.70M shares 10-Q · filed 2020-11-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |